Avience Biomedicals Limited
SMEAVIENCE • NSE
Issue details
Price band
₹196 - ₹208
Lot size
600 shares
Issue size
₹30 Cr
Min. investment
₹1,24,800
Registrar
Skyline Financial Services
Grey market premium
Save your family's PANs once and check allotment for everyone the moment results are out.
Sign in with a mobile OTP. It takes 20 seconds.
IPO Timeline
Open
18 Jun
Close
22 Jun
Allotment
23 Jun
Listing
25 Jun
- Refunds & demat credit
- 24 Jun 2026
- Mandate end
- 7 Jul 2026
We calculate these dates from the allotment and close dates, so please treat them as indicative.
Application size
| Category | Minimum | Maximum |
|---|---|---|
| Retail | 600shares 1 lot · ₹1,24,800 | 600shares 1 lot · ₹1,24,800 |
| HNI | 1,200shares 2 lots · ₹2,49,600 | No limit funds permitting |
Based on the upper price band of ₹208 and a lot of 600 shares.
Issue structure
Face value
₹10 per share
Issue type
Bookbuilding IPO
Sale type
Fresh capital only
Fresh issue
₹29 Cr
13,71,600 shares
Shares pre-issue
40,31,256
Shares post-issue
54,85,056
Reservation
- QIB
- 6,83,400
- NII
- 2,07,000
- Retail
- 4,81,200
Valuation & ratios
| Metric | Pre-IPO | Post-IPO |
|---|---|---|
| EPS | 17.94 | 12.56 |
| P/E | 11.59 | 16.56 |
| Market cap | ₹83.85 Cr. | ₹227.60 Cr |
| KPI | Jan 31, 206 | Mar 31, 2025 |
|---|---|---|
| ROE | 22.38% | 50.14% |
| ROCE | 16.99% | 24.84% |
| Debt/Equity | 0.94 | 0.97 |
| RoNW | 22.38% | 49.89% |
| PAT Margin | — | 15.86% |
| EBITDA Margin | 24.70% | 25.22% |
| NAV | 70.74 | 56.50 |
| Price to Book Value | 2.94 | 3.68 |
Financials
| Metric | 31 Jan 2026 | 31 Mar 2025 | 31 Mar 2024 |
|---|---|---|---|
| Total income | 41.94 | 45.97 | 24.37 |
| Profit after tax | 5.74 | 7.23 | 2.14 |
| EBITDA | 10.34 | 11.41 | 4.08 |
| Net worth | 28.52 | 22.78 | 6.21 |
| Assets | 66.07 | 56.52 | 34.65 |
| Reserves & surplus | 24.49 | 18.75 | 2.93 |
| Total borrowing | 26.73 | 22.16 | 15.13 |
Figures in ₹ crore, as reported by the company in its offer document.
Objects of the issue
- 1.Part finances the capital expenditure towards setting up of a new manufacturing unit at industrial plot no. 70, Sector 28 in the Medical Device Park under the Yamuna Expressway Industrial Development Authority (YEIDA), Gautam Buddha Nagar, Uttar Pradesh₹14.05 Cr
- 2.Funding the working capital requirements of the Company₹8.25 Cr
- 3.General Corporate Purposes₹3.97 Cr
- 4.Public Issue Expenses₹3.97 Cr
What the company says it intends to do with the money raised.
Recent comparable IPOs
| Company | Issue price | P/E | Listing close | Listing gain |
|---|---|---|---|---|
| Anthem Biosciences Ltd.Mainboard | ₹570 | 70.62 | ₹730.35 | +28.13% |
Past listing performance of comparable issues. This is not a forecast: listing gains vary widely and can turn negative.
Issue fundamentals compiled from the company's offer document via Chittorgarh, last read 27 Sep 2026. Always verify against the RHP before applying.